Parotid mucoepidermoid carcinoma with extensive intravenous metastasis: a case report

Main Article Content

Alice Flavell-Birch
Helen D Brasch
Swee T Tan

Keywords

mucoepidermoid carcinoma, head and neck neoplasm, parotid gland

Abstract

Salivary tumours are uncommon, comprising only 2–5 per cent of head and neck neoplasms,1 with mucoepidermoid carcinoma (MEC) being the most common salivary cancer in both adults and children.1–4 Clinically, head and neck MEC can present variably from being asymptomatic to locally or metastatically aggressive.5,6 Treatment is primary surgical resection with neck dissection. The use of adjuvant radiotherapy is indicated for patients at high risk of recurrence, such as those with a high tumour stage, positive resection margins and high histological grading.6–8 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Abstract 47 | PDF Downloads 15 HTML Downloads 11

References

Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2899–906. https://doi.org/10.1158/1055-9965.EPI-09-0638 PMid:19861510 PMCid:PMC2779732
2. Isayeva T, Said-Al-Naief N, Ren Z, Li R, Gnepp D, Brandwein-Gensler M. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18. Head Neck Pathol. 2013;7(2):135–48. https://doi.org/10.1007/s12105-012-0411-2 PMid:23233027 PMCid:PMC3642267
3. Guevara-Canales J-O, Morales-Vadillo R, Guzmán-Arias G, Cava-Vergiú C-E, Robello-Malatto J-M, Guerra-Miller H, Montes-Gil J-E. Mucoepidermoid carcinoma of the salivary glands: survival and prognostic factors. J Maxillofac Oral Surg. 2017;16(4):431–37. https://doi.org/10.1007/s12663-016-0946-y PMid:29038625 PMCid:PMC5628063
4. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg. 1986;8(3):177–84. https://doi.org/10.1002/hed.2890080309 PMid:3744850
5. Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, Lai S Y. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113(8):2082–89. https://doi.org/10.1002/cncr.23825 PMid:18720358 PMCid:PMC2746751
6. Son E, Panwar A, Mosher CH, Lydiatt D. Cancers of the major salivary glands. Am Soc Clin Oncol. 2018;14(2):99–108. https://doi.org/10.1200/JOP.2017.026856 PMid:29436307
7. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Merrill SK, Weber RS, Kupferman ME. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118(16):3928–36. https://doi.org/10.1002/cncr.26697 PMid:22180391
8. Robbins S, Kumar V. Pathologic basis of disease, 8th ed. Philadelphia, PA: Saunders/Elsevier, 2010; ch 7, 20.
9. Galdirs TM, Kappler M, Reich W, Eckert AW. Current aspects of salivary gland tumors—a systematic review of the literature. GMS Interdiscip Plast Reconstr Surg DGPW. 2019;8:Doc12. https://doi.org/10.3205/iprs000138 PMCID: PMC6734194 PMID: 31523610
10. Katabi N, Ghossein R, Ali S, Dogan S, Klimstra D, Ganly I. Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading. Histopathology. 2014;65(6):793–804. https://doi.org/10.1111/his.12488 PMid:25040772